Novel fluoroquinolones analogues bearing 4-(arylcarbamoyl)benzyl: design, synthesis, and antibacterial evaluation. 2023

Fariba Peytam, and Maryam Norouzbahari, and Toktam Saadattalab, and Gizem Şanlıtürk, and Loghman Firoozpour, and Zahra Emamgholipour, and Mahtab Ghasemi Dogaheh, and Mohammad Nikou, and Maliheh Barazandeh Tehrani, and Hamid Reza Bijanzadeh, and Mümtaz Güran, and Alireza Foroumadi
Drug Design and Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran.

Bacterial resistance to fluoroquinolone has been increasing at an alarming rate worldwide. In an attempt to find more potent anti-bacterial agents, an efficient, straightforward protocol was performed to obtain a large substrate scope of novel ciprofloxacin and sarafloxacin analogues conjugated with 4-(arylcarbamoyl)benzyl 7a-ab. All prepared compounds were evaluated for their anti-bacterial activities against three gram-positive strains (Methicillin resistant staphylococcus aureus (MRSA), Staphylococcus aureus, and Enterococcus faecalis) as well as three gram-negative strains (Pseudomonas aeruginosa, Klebsiella pneumonia, and Escherichia coli) through three standard methods including broth microdilution, agar-disc diffusion, and agar-well diffusion assays. Most of the compounds exhibited great to excellent anti-bacterial potencies against MRSA and S. aureus. Among the targeted compounds, derivative 7n exhibited great antibacterial potency, which was noticeably more potent than parent ciprofloxacin. Subsequently, a molecular docking study was performed for this compound to find out its probable binding mode with the active site of S. aureus DNA gyrase (PDB ID: 2XCT).

UI MeSH Term Description Entries

Related Publications

Fariba Peytam, and Maryam Norouzbahari, and Toktam Saadattalab, and Gizem Şanlıtürk, and Loghman Firoozpour, and Zahra Emamgholipour, and Mahtab Ghasemi Dogaheh, and Mohammad Nikou, and Maliheh Barazandeh Tehrani, and Hamid Reza Bijanzadeh, and Mümtaz Güran, and Alireza Foroumadi
July 2013, Bioorganic & medicinal chemistry letters,
Fariba Peytam, and Maryam Norouzbahari, and Toktam Saadattalab, and Gizem Şanlıtürk, and Loghman Firoozpour, and Zahra Emamgholipour, and Mahtab Ghasemi Dogaheh, and Mohammad Nikou, and Maliheh Barazandeh Tehrani, and Hamid Reza Bijanzadeh, and Mümtaz Güran, and Alireza Foroumadi
December 2020, Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences,
Fariba Peytam, and Maryam Norouzbahari, and Toktam Saadattalab, and Gizem Şanlıtürk, and Loghman Firoozpour, and Zahra Emamgholipour, and Mahtab Ghasemi Dogaheh, and Mohammad Nikou, and Maliheh Barazandeh Tehrani, and Hamid Reza Bijanzadeh, and Mümtaz Güran, and Alireza Foroumadi
September 2020, European journal of medicinal chemistry,
Fariba Peytam, and Maryam Norouzbahari, and Toktam Saadattalab, and Gizem Şanlıtürk, and Loghman Firoozpour, and Zahra Emamgholipour, and Mahtab Ghasemi Dogaheh, and Mohammad Nikou, and Maliheh Barazandeh Tehrani, and Hamid Reza Bijanzadeh, and Mümtaz Güran, and Alireza Foroumadi
August 2004, Archiv der Pharmazie,
Fariba Peytam, and Maryam Norouzbahari, and Toktam Saadattalab, and Gizem Şanlıtürk, and Loghman Firoozpour, and Zahra Emamgholipour, and Mahtab Ghasemi Dogaheh, and Mohammad Nikou, and Maliheh Barazandeh Tehrani, and Hamid Reza Bijanzadeh, and Mümtaz Güran, and Alireza Foroumadi
November 2016, Bioorganic & medicinal chemistry letters,
Fariba Peytam, and Maryam Norouzbahari, and Toktam Saadattalab, and Gizem Şanlıtürk, and Loghman Firoozpour, and Zahra Emamgholipour, and Mahtab Ghasemi Dogaheh, and Mohammad Nikou, and Maliheh Barazandeh Tehrani, and Hamid Reza Bijanzadeh, and Mümtaz Güran, and Alireza Foroumadi
March 2008, Bioorganic & medicinal chemistry letters,
Fariba Peytam, and Maryam Norouzbahari, and Toktam Saadattalab, and Gizem Şanlıtürk, and Loghman Firoozpour, and Zahra Emamgholipour, and Mahtab Ghasemi Dogaheh, and Mohammad Nikou, and Maliheh Barazandeh Tehrani, and Hamid Reza Bijanzadeh, and Mümtaz Güran, and Alireza Foroumadi
February 2018, Bioorganic & medicinal chemistry,
Fariba Peytam, and Maryam Norouzbahari, and Toktam Saadattalab, and Gizem Şanlıtürk, and Loghman Firoozpour, and Zahra Emamgholipour, and Mahtab Ghasemi Dogaheh, and Mohammad Nikou, and Maliheh Barazandeh Tehrani, and Hamid Reza Bijanzadeh, and Mümtaz Güran, and Alireza Foroumadi
July 2016, Chemical & pharmaceutical bulletin,
Fariba Peytam, and Maryam Norouzbahari, and Toktam Saadattalab, and Gizem Şanlıtürk, and Loghman Firoozpour, and Zahra Emamgholipour, and Mahtab Ghasemi Dogaheh, and Mohammad Nikou, and Maliheh Barazandeh Tehrani, and Hamid Reza Bijanzadeh, and Mümtaz Güran, and Alireza Foroumadi
November 2006, Bioorganic & medicinal chemistry,
Fariba Peytam, and Maryam Norouzbahari, and Toktam Saadattalab, and Gizem Şanlıtürk, and Loghman Firoozpour, and Zahra Emamgholipour, and Mahtab Ghasemi Dogaheh, and Mohammad Nikou, and Maliheh Barazandeh Tehrani, and Hamid Reza Bijanzadeh, and Mümtaz Güran, and Alireza Foroumadi
February 2020, European journal of medicinal chemistry,
Copied contents to your clipboard!